Saab receives Swedish underwater weapons order
Saab will perform work to upgrade the heavyweight torpedo Torpedo 62 under a new contract received from the Swedish Defence Material Administration announced on 14 December. In a separate agreement, the company will also provide support for underwater weapon systems.
The upgrade of Torpedo 62 comprises of new and improved functions for communication and warhead initiation, providing an important capability enhancement for the system.
The Torpedo 62 is an advanced heavy weight torpedo for combating surface targets. The system is equipped with an advanced propulsion system capable of high speed and long endurance together with a state of the art homing system.
Tomas Samuelsson, head of business area dynamics, Saab, said: ‘The Torpedo 62 system will, as a result of this order, be upgraded with new functionality and gain increased capability. I feel satisfied to report yet another order from one of the market’s most demanding customers.’
The two contracts have a combined value of MSEK 194. Deliveries pertaining to these contracts will take place during the period 2013 to 2016.
More from Naval Warfare
-
Patrol vessel demand and partnerships anchor North Africa's naval market
Fincantieri and Naval Group are positioning for long-term work in Egypt and Morocco as demand for local industrial partnerships grows.
-
UK MoD faces ‘serious’ ASW gap as Defence Committee outlines Arctic requirements
Anti-submarine warfare, uncrewed vessels and seabed monitoring top the demand list in the Defence Committee’s High North roadmap for the 2030s.
-
Autonomy gives Turkey a chance to outflank established naval shipbuilders
Turkish shipbuilders have sold ships from Asia to Europe, but autonomy and swarm technology could give them a fairer fight against Western European rivals.
-
Canada assesses security equipment changes for Polar Icebreaker Imnaryuaq
The Canadian Department of National Defence is evaluating communications and reconnaissance changes for CCGS Imnaryuaq’s expanded maritime security role, while retaining its 2032 acceptance target.